Cause of death and excess mortality in patients with lower‐risk myelodysplastic syndromes (MDS): A report from the European <scp>MDS</scp> registry-Reference-Cited by-同舟云学术

Cause of death and excess mortality in patients with lower‐risk myelodysplastic syndromes (MDS): A report from the European MDS registry

Published:2022-11-06 Issue:4 Volume:200 Page:451-461
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Mądry Krzysztof¹^ORCID,Lis Karol¹,Fenaux Pierre²^ORCID,Bowen David³,Symeonidis Argiris⁴^ORCID,Mittelman Moshe⁵^ORCID,Stauder Reinhard⁶^ORCID,Čermák Jaroslav⁷,Sanz Guillermo⁸,Hellström‐Lindberg Eva⁹,Langemeijer Saskia¹⁰^ORCID,Malcovati Luca¹¹,Germing Ulrich¹²,Holm Mette Skov¹³,Guerci‐Bresler Agnes¹⁴,Culligan Dominic¹⁵,Sanhes Laurence¹⁶,Kotsianidis Ioannis¹⁷,van Marrewijk Corine¹⁰,Crouch Simon¹⁸,de Witte Theo¹⁹,Smith Alex¹⁸^ORCID,

Affiliation:

1. Department of Haematology, Transplantation and Internal Medicine Warszawa Medical University Warsaw Poland

2. Service d'Hématologie, Hôpital Saint‐Louis Assistance Publique des Hôpitaux de Paris (AP‐HP) and Université Paris 7 Paris France

3. St. James's Institute of Oncology Leeds Teaching Hospitals Leeds UK

4. Department of Medicine, Division of Hematology University of Patras Medical School Patras Greece

5. Department of Medicine A, Tel Aviv Sourasky (Ichilov) Medical Center and Sackler Medical Faculty Tel Aviv University Tel Aviv Israel

6. Department of Internal Medicine V (Haematology and Oncology) Innsbruck Medical University Innsbruck Austria

7. Department of Clinical Hematology Institute of Hematology & Blood Transfusion Praha Czech Republic

8. Department of Haematology Hospital Universitario y Politécnico La Fe & Scientific Director IIS La Fe Madrid Spain

9. Department of Medicine, Division of Hematology Karolinska Institutet Stockholm Sweden

10. Department of Hematology Radboud University Medical Center Nijmegen the Netherlands

11. Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo University of Pavia Pavia Italy

12. Department of Haematology, Oncology and Clinical Immunology Universitätsklinik Düsseldorf Düsseldorf Germany

13. Department of Haematology Aarhus University Hospital Aarhus Denmark

14. Service d'Hématologie, Centre Hospitalier Universtaire Brabois Vandoeuvre Nancy France

15. Department of Haematology Aberdeen Royal Infirmary Aberdeen UK

16. Service d'Hématologie, Centre Hospitalier de Perpignan Perpignan France

17. Department of Hematology Democritus University of Thrace Medical School, University Hospital of Alexandroupolis Alexandroupolis Greece

18. Epidemiology and Cancer Statistics Group, Department of Health Sciences University of York York UK

19. Department of Tumor Immunology – Nijmegen Center for Molecular Life Sciences Radboud University Medical Center Nijmegen the Netherlands

Funder

Janssen Pharmaceuticals

Takeda Pharmaceuticals International

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18542

Reference21 articles.

1. International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes

2. Revised International Prognostic Scoring System for Myelodysplastic Syndromes

3. Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry

4. Causes of death in 2877 patients with myelodysplastic syndromes

5. Cause of death in patients with lower-risk myelodysplastic syndrome

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MDS patient registries - achievements and challenges;Annals of Hematology;2024-08-23

2. Infections and antimicrobial prophylaxis in patients with myelodysplastic syndromes;Seminars in Hematology;2024-08

3. Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome;Current Treatment Options in Oncology;2024-05-30

4. Infectious Complications in Patients with Myelodysplastic Syndromes: A Report from the Düsseldorf MDS Registry;Cancers;2024-02-16

5. Cardiac effects of deferasirox in transfusion‐dependent patients with myelodysplastic syndromes: TELESTO study;British Journal of Haematology;2024-02-11